LARRY BOUSQUET: Open Payments
NPI 1205544871 · FORT MOHAVE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 21 payments from 8 companies in 2025. Trend: 2023 $252 · 2024 $298 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $159 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Lilly USA, LLC | 2 | $43 |
| Dexcom, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Viatris Specialty LLC | 1 | $33 |
| PFIZER INC. | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $25 |
Products named: Ozempic, AIRSUPRA, MOUNJARO, Dexcom G6 Transmitter, TRELEGY ELLIPTA, YUPELRI, INJECTAFER, ELIQUIS.
Industry payments across AZ — which companies pay providers there.
